My goal has always been to draw a clear line on defining what a traditional compounding pharmacy is, and that should be regulated by the States, and what a manufacturer, a drug manufacturer is, which properly should be regulated by the FDA.
Pitts emphasizes the need to distinguish between compounding pharmacies and drug manufacturers for regulation.
Share
More from Joe Pitts
In 2008, Congress passed a bill requiring most group health plans to provide more generous coverage for treatment of mental illnesses.
Today's Health Subcommittee hearing will examine the Federal mental health parity laws and regulations.
Today's hearing is an important discussion that will examine the areas where we can improve our national trauma system.
Other voices in this conversation
